Cargando…

Interim prostacyclin therapy for an isolated disconnected pulmonary artery: a case report

INTRODUCTION: Disconnected pulmonary arteries are unusual and may result in pulmonary hypertension with acute right heart failure. CASE PRESENTATION: We report a case of a three-month-old Asian girl who presented with heart failure and severe pulmonary hypertension due to a disconnected right pulmon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grech, Victor, Grixti, Cynthia
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Case report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894860/ https://www.ncbi.nlm.nih.gov/pubmed/20525186 http://dx.doi.org/10.1186/1752-1947-4-168

Ejemplares similares

Subdural hematomas in pulmonary arterial hypertension patients treated with prostacyclin analogs
por: Louis, Lam, et al.
Publicado: (2012)

Impact of additional selexipag on prostacyclin infusion analogs in patients with pulmonary arterial hypertension
por: Momoi, Mizuki, et al.
Publicado: (2022)

Transition from parental prostacyclin to selexipag: a case series of five pulmonary arterial hypertension patients
por: Holthaus, Nathan, et al.
Publicado: (2019)

Hemodynamic rounds: Dilemma in the management of disconnected pulmonary arteries with double arterial ducts
por: Sivakumar, Kothandam, et al.
Publicado: (2022)

The use of selexipag, a prostacyclin receptor analog, for treatment of severe pulmonary artery hypertension during pregnancy, a case report
por: Khan, Akram, et al.
Publicado: (2023)

Effectiveness of stenting and subsequent re‐implantation of disconnected pulmonary artery to restore the pulmonary hemodynamics
por: Khoshhal, Saad, et al.
Publicado: (2021)

First-in-child use of the oral selective prostacyclin IP receptor agonist selexipag in pulmonary arterial hypertension
por: Geerdink, Lianne M., et al.
Publicado: (2017)

Combination Therapy in Pulmonary Arterial Hypertension—Targeting the Nitric Oxide and Prostacyclin Pathways
por: Mandras, Stacy, et al.
Publicado: (2021)

Balloon atrial septostomy and transition of subcutaneous to intravenous prostacyclin infusion for rescuing advanced right heart failure in idiopathic pulmonary arterial hypertension: a case report
por: Liang, Kae-Woei, et al.
Publicado: (2020)

Use of prostacyclin in pulmonary hypertension
por: Vicente, R, et al.
Publicado: (1998)

Role of prostacyclin in pulmonary hypertension
por: Mitchell, Jane A., et al.
Publicado: (2014)

Clinical and genetic associations with prostacyclin response in pulmonary arterial hypertension
por: Halliday, Stephen J., et al.
Publicado: (2018)

Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension
por: Lang, Irene M., et al.
Publicado: (2015)

Brainstem disconnection
por: Duffield, Curtis, et al.
Publicado: (2009)

Disconnection of pulmonary and systemic arterial stiffness in COPD
por: Weir-McCall, Jonathan R, et al.
Publicado: (2018)

Management of prostacyclin side effects in adult patients with pulmonary arterial hypertension
por: Kingman, Martha, et al.
Publicado: (2017)

The Acute Effects of Prostacyclin on Right Ventricular Contractility and Pulmonary Artery Coupling
por: Vanderpool, Rebecca R., et al.
Publicado: (2023)

Incremental value of fetal spatiotemporal image correlation echocardiography in the diagnosis of tetralogy of Fallot with disconnected pulmonary arteries with ductus arteriosus supplying the left pulmonary artery
por: Karapurkar, Sonia, et al.
Publicado: (2023)

The rarest aortic arch anomaly a case report of asymptomatic isolation of the subclavian artery
por: Taliana, N, et al.
Publicado: (2017)

Partial disconnection procedure in a patient with bilateral lesions (case report)()
por: Stepanenko, Alexey Y., et al.
Publicado: (2013)

An Effective Case for Chyluria by Retroperitoneoscopic Lymphatic Disconnection
por: Tomisaki, Ikko, et al.
Publicado: (2016)

Saudi experience in the management of pulmonary arterial hypertension; the outcome of PAH therapy with the exclusion of chronic parenteral prostacyclin
por: Idrees, Majdy, et al.
Publicado: (2015)

Prognosis of pulmonary arterial hypertension patients with pericardial effusion before and after initiation of parenteral prostacyclin therapy
por: Abu‐Rmaileh, Muhammad, et al.
Publicado: (2023)

Re; Dilemma in the management of disconnected pulmonary arteries with double arterial ducts
por: Kothari, Shyam Sunder
Publicado: (2022)

Management of the late effects of disconnected pancreatic duct syndrome: A case report
por: Yamada, Reiko, et al.
Publicado: (2019)

The pulmonary and haematological toxicity of inhaled aerosolised prostacyclin
por: van Heerden, PV, et al.
Publicado: (1997)

Disconnected Pancreatic Duct Syndrome: A Case Series
por: Satyam, Satyam, et al.
Publicado: (2022)

Isolated Left Pulmonary Artery Agenesis: A Case Report
por: Balcı, Tansel Ansal, et al.
Publicado: (2012)

Isolated agenesis of the left pulmonary artery: A case report
por: Mpe, M J, et al.
Publicado: (2021)

Additional Use of Prostacyclin Analogs in Patients With Pulmonary Arterial Hypertension: A Meta-Analysis
por: Wang, Pengwei, et al.
Publicado: (2022)

New Tricks for an Old Drug: Prostacyclins and Right Ventricular Contractility in Pulmonary Arterial Hypertension
por: Wertheim, Bradley M.
Publicado: (2022)

Hypoxia–Reoxygenation Triggers Coronary Vasospasm in Isolated Bovine Coronary Arteries via Tyrosine Nitration of Prostacyclin Synthase
por: Zou, Ming-Hui, et al.
Publicado: (1999)

A Report of a Novel Mutation in Human Prostacyclin Receptor Gene in Patients Affected with Migraine
por: Kheirollahi, Majid, et al.
Publicado: (2017)

Transition from parenteral prostacyclins to selexipag: safety and feasibility in selected patients
por: Aldweib, Nael, et al.
Publicado: (2021)

A multicenter, retrospective study of patients with pulmonary arterial hypertension transitioned from parenteral prostacyclin therapy to inhaled iloprost
por: Channick, Richard N., et al.
Publicado: (2013)

Comparative Efficacy and Safety of Prostacyclin Analogs for Pulmonary Arterial Hypertension: A Network Meta-Analysis
por: Zhang, Huijun, et al.
Publicado: (2016)

Resource utilization at the time of prostacyclin initiation in children in pulmonary arterial hypertension: a multicenter analysis
por: Hart, Stephen A., et al.
Publicado: (2018)

Adverse Events of Prostacyclin Mimetics in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis
por: Picken, Christina, et al.
Publicado: (2019)

Transitions between infused and oral prostacyclin pathway agents in pulmonary arterial hypertension: key considerations
por: Sargent, Therese, et al.
Publicado: (2020)

Practical considerations for therapies targeting the prostacyclin pathway
por: Farber, Harrison W., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1nm8iqk99hkhkj50efi54bd7fl